Asset Management One Co., Ltd. - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Asset Management One Co., Ltd. ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2022$551,000
-30.6%
13,3140.0%0.00%
-25.0%
Q2 2022$794,000
-17.8%
13,3140.0%0.00%0.0%
Q1 2022$966,000
-12.3%
13,3140.0%0.00%0.0%
Q4 2021$1,101,000
-8.2%
13,3140.0%0.00%
-20.0%
Q3 2021$1,200,000
-5.4%
13,3140.0%0.01%0.0%
Q2 2021$1,269,000
-16.2%
13,3140.0%0.01%
-16.7%
Q1 2021$1,515,000
-22.8%
13,3140.0%0.01%
-25.0%
Q4 2020$1,963,000
+79.4%
13,3140.0%0.01%
+60.0%
Q3 2020$1,094,000
-23.1%
13,314
-26.8%
0.01%
-28.6%
Q2 2020$1,423,000
+76.1%
18,1870.0%0.01%
+40.0%
Q1 2020$808,000
+4.0%
18,1870.0%0.01%
+25.0%
Q4 2019$777,000
-0.1%
18,1870.0%0.00%0.0%
Q3 2019$778,000
-32.6%
18,1870.0%0.00%
-33.3%
Q2 2019$1,155,000
-54.5%
18,187
-50.4%
0.01%
-57.1%
Q1 2019$2,541,000
+95.5%
36,636
+18.4%
0.01%
+366.7%
Q4 2018$1,300,000
-48.0%
30,930
-1.3%
0.00%
-40.0%
Q3 2018$2,502,000
-14.3%
31,351
-18.2%
0.01%
-16.7%
Q2 2018$2,919,000
+17.9%
38,333
-21.0%
0.01%0.0%
Q1 2018$2,475,000
+8.6%
48,5390.0%0.01%
+20.0%
Q4 2017$2,280,000
-13.0%
48,5390.0%0.01%
-16.7%
Q3 2017$2,620,000
-12.8%
48,5390.0%0.01%
-25.0%
Q2 2017$3,004,000
+8.3%
48,539
+17.8%
0.01%
+14.3%
Q1 2017$2,774,000
+67.4%
41,219
+74.5%
0.01%
+75.0%
Q4 2016$1,657,000
+14.8%
23,619
+12.4%
0.00%
-81.0%
Q3 2016$1,443,000
+715.3%
21,017
+486.7%
0.02%
+600.0%
Q2 2016$177,0003,5820.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023
NameSharesValueWeighting ↓
First Light Asset Management, LLC 437,512$31,772,0002.80%
RTW INVESTMENTS, LP 1,373,284$99,728,0002.06%
Rock Springs Capital Management LP 1,028,109$74,661,0001.88%
Privium Fund Management B.V. 112,727$8,186,0001.81%
Avidity Partners Management LP 869,000$63,107,0001.31%
SUVRETTA CAPITAL MANAGEMENT, LLC 525,100$38,133,0001.16%
Boxer Capital, LLC 200,000$14,524,0000.75%
SECTOR GAMMA AS 46,221$3,357,0000.73%
FEDERATED HERMES, INC. 3,987,728$289,589,0000.65%
EMERALD ADVISERS, LLC 223,952$16,263,0000.62%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders